AnaptysBio, Inc. (ANAB)
NASDAQ: ANAB · Real-Time Price · USD
21.63
-0.55 (-2.48%)
At close: Oct 31, 2024, 4:00 PM
21.00
-0.63 (-2.91%)
After-hours: Oct 31, 2024, 5:53 PM EDT
AnaptysBio Market Cap
AnaptysBio has a market cap or net worth of $653.22 million as of October 31, 2024. Its market cap has increased by 30.07% in one year.
Market Cap
653.22M
Enterprise Value
697.95M
1-Year Change
30.07%
Ranking
Category
Stock Price
$21.63
Market Cap Chart
Since January 26, 2017, AnaptysBio's market cap has increased from $308.70M to $653.22M, an increase of 111.60%. That is a compound annual growth rate of 10.13%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Oct 30, 2024 | 608.80M | 6.96% |
Dec 29, 2023 | 569.20M | -35.40% |
Dec 30, 2022 | 881.10M | -7.83% |
Dec 31, 2021 | 955.90M | 62.57% |
Dec 31, 2020 | 588.00M | 33.36% |
Dec 31, 2019 | 440.90M | -74.16% |
Dec 31, 2018 | 1.71B | -27.90% |
Dec 29, 2017 | 2.37B | 666.67% |
Jan 26, 2017 | 308.70M | - |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Zymeworks | 940.67M |
Cullinan Therapeutics | 936.32M |
Liquidia | 930.69M |
Rapport Therapeutics | 922.82M |
PetIQ | 919.17M |
Pliant Therapeutics | 903.51M |
Castle Biosciences | 898.67M |
HealthStream | 880.51M |